
High response seen for chemo in seniors with high-risk AML
(HealthDay)—A substantial proportion of older patients with high-risk acute myeloid leukemia (AML) treated with chemotherapy are long-term survivors, according to research published online June 7 in Cancer Medicine.
Jun 20, 2019
0
0